Patients in the endovascular therapy group achieved greater functional outcomes at 90 days. 2. Endovascular therapy resulted in significantly decreased disability and overall mortality. Evidence ...

Polypharmacy was associated with a greater risk of mortality and hospitalizations at one and five years. Evidence Rating ...

CDASI-A score at 12 weeks was significantly lower in dazukibart 600 mg versus placebo, suggesting reduced morbidity. 2.

From 2002 to 2021, the incidence rate of alcohol-associated hepatitis in Ontario, Canada increased by 8% annually, with rates ...

Association between blood–urea–nitrogen-to-albumin ratio and in-hospital mortality in patients diagnosed with coronavirus ...

In three cohorts of healthcare professionals, diet was associated with long-term health after adjusting for individual- and ...

In this systematic review, patients with episodic migraine preferred oral pharmacologic treatments that reduced the severity, ...

In this cohort of adults in the United Kingdom (UK), those with a thinner or plumper body size in childhood had an increased ...

In this randomized controlled trial, the enhanced recovery after surgery (ERAS) protocol led to a decrease in post-operative ...

There were no serious adverse events or treatment-related mortalities. Evidence Rating Level: 2 (Good) Study Rundown: ...

Functional recovery at 90 days was lower in the balloon-guided catheter group versus the conventional catheter group. 2.

The use of fecal microbiota, live-jslm (RBL; REBYOTA®) in the prevention of recurrent Clostridioides difficile infection ...